The interaction between ER and NFκB in resistance to endocrine therapy

Endocrine therapy is a commonly used treatment for estrogen receptor (ER)-positive breast cancer. Although endocrine therapy has a favorable outcome in many patients, development of resistance is common. Recent studies have shown that NFκB, a transcription factor regulating a wide variety of cellula...

Descripción completa

Detalles Bibliográficos
Autores principales: Sas, Leen, Lardon, Filip, Vermeulen, Peter B, Hauspy, Jan, Van Dam, Peter, Pauwels, Patrick, Dirix, Luc Y, Van Laere, Steven J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680926/
https://www.ncbi.nlm.nih.gov/pubmed/22963717
http://dx.doi.org/10.1186/bcr3196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680926/
https://www.ncbi.nlm.nih.gov/pubmed/22963717
http://dx.doi.org/10.1186/bcr3196

Ejemplares similares